Dynamic Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,895
Closed -$279K 147
2017
Q4
$279K Sell
3,895
-62,725
-94% -$4.76M 0.1% 199
2017
Q3
$5.4M Buy
66,620
+50,649
+317% +$3.87M 1.55% 13
2017
Q2
$1.13M Buy
+15,971
New +$1.06M 0.26% 89
2015
Q4
Sell
-8,027
Closed -$788K 378
2015
Q3
$788K Buy
+8,027
New +$892K 0.22% 189
2015
Q2
Sell
-3,100
Closed -$304K 295
2015
Q1
$304K Sell
3,100
-2
-0.1% -$203 0.11% 187
2014
Q4
$292K Buy
+3,102
New +$321K 0.15% 178
2014
Q3
Sell
-5,918
Closed -$491K 372
2014
Q2
$491K Sell
5,918
-10,882
-65% -$847K 0.14% 250
2014
Q1
$1.19M Buy
16,800
+13,735
+448% +$1.08M 0.39% 69
2013
Q4
$230K Buy
+3,065
New +$213K 0.04% 370

Other funds holding GILD

Dynamic Capital Management's GILD Position: Q1 2018 in Review

Dynamic Capital Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 3,895 shares — an estimated $279K sold.

Dynamic Capital Management first reported a position in GILD in Q4 2013 and held it in 9 quarters. The position peaked at $5.4M in Q3 2017. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Dynamic Capital Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Dynamic Capital Management sold 3,895 Gilead Sciences shares in Q1 2018, an estimated $279K.
  • Dynamic Capital Management first reported a position in Gilead Sciences in Q4 2013 and held it in 9 quarters.
  • Dynamic Capital Management's Gilead Sciences position peaked at $5.4M in Q3 2017.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Dynamic Capital Management's 13F filing for Q1 2018, filed 14 May 2018.